Insider Ledger
CMMB insider buying and SEC filings, explained
Chemomab Therapeutics Ltd. · CIK 1534248
Tracked: Forms 3/4/5, 8-K, NT · Limited coverage: files 6-K/20-F, not covered in v1 · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Pharmaceutical Preparations
- State of incorporation
- L3
- Fiscal year end
- Dec 31
- Former names
- Anchiano Therapeutics Ltd.; BioCancell Ltd.
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$7K
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Aug 27–28, 2026 | Sale | Neil Harris Cohen (Director) sold 2,304 shares between Aug 27 and Aug 28 at about $2.83 ($7K). Holdings down 7% to 33,000 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 1, 2026 |
| May 29, 2026 | Other purchase | George Adi Mor (CEO and Director) bought 9,804 American Depositary Shares at about $2.07 ($20K), reported as a purchase (code P). Holdings down 7% to 139,131 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 1, 2026 |
2 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow CMMB in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.